XML 18 R4.htm IDEA: XBRL DOCUMENT v3.22.4
Consolidated Statements of Operations and Comprehensive Loss - USD ($)
shares in Thousands, $ in Thousands
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Revenues $ 256,513 $ 211,949
Cost of goods sold 262,048 204,010
Gross (loss) profit (5,535) 7,939
Research and development expenses 180 88
Selling, general and administrative expenses 28,686 23,676
Operating loss (34,401) (15,825)
Interest expense    
Interest rate expense 21,407 20,136
Debt related fees and amortization expense 7,363 3,921
Accretion and other expenses of Series A preferred units 9,888 7,718
Loss (gain) on debt extinguishment 49,386 (1,134)
Gain on litigation (1,400) 0
Other (income) expense (14,340) 809
Loss before income taxes (106,705) (47,275)
Income tax expense (benefit) 1,053 (128)
Net loss (107,758) (47,147)
Other comprehensive (loss)    
Foreign currency translation loss (1,102) (236)
Comprehensive loss $ (108,860) $ (47,383)
Net loss per common share    
Basic (in dollars per share) $ (3.12) $ (1.54)
Diluted (in dollars per share) $ (3.12) $ (1.54)
Weighted average shares outstanding    
Basic (in shares) 34,585 30,682
Diluted (in shares) 34,585 30,682